Korea S.E.
18:00:00 2024-05-27 EDT
5-day change
1st Jan Change
4,930
KRW
+1.44%
-1.40%
-6.63%
Yuyu Pharma, Inc. announced that it has received KRW 30 billion in funding from a group of investors
On June 15, 2021, Yuyu Pharma, Inc. (KOSE:A000220) closed the transaction.
Yuyu Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
05-15
CI
Yuyu Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
03-20
CI
Yuyu Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
11-14
CI
Yuyu Pharma, Inc. announced that it has received KRW 24.5 billion in funding from a group of investors
23-05-21
CI
Yuyu Pharma, Inc. announced that it expects to receive KRW 24.5 billion in funding from a group of investors
23-05-17
CI
Yuyu Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-15
CI
Yuyu Pharma Unveils the Results of Its Mechanism of Action and Head-To- Head Studies for Its Dry Eye Treatment Peptide
23-04-27
CI
Yuyu Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
22-11-14
CI
Tranche Update on Yuyu Pharma, Inc.'s Equity Buyback Plan announced on September 19, 2022.
22-10-24
CI
Tranche Update on Yuyu Pharma, Inc.'s Equity Buyback Plan announced on September 19, 2022.
22-10-24
CI
Yuyu Pharma, Inc.'s Equity Buyback announced on September 19, 2022, has closed with 304,878 shares, representing 1.83% for KRW 1,785.24 million.
22-10-19
CI
Yuyu Pharma, Inc. announces an Equity Buyback for 304,878 shares.
22-09-18
CI
Yuyu Pharma, Inc. authorizes a Buyback Plan.
22-09-18
CI
Yuyu Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
22-08-16
CI
Yuyu Pharma Announces First Patient Enrolled in Phase 2 Clinical Study Evaluating YP-P10 Ophthalmic Solution for the Treatment of Dry Eye Disease
22-07-20
CI
Yuyu Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
22-05-13
CI
Yuyu Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
22-03-23
CI
Yuyu Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
21-11-15
CI
Yuyu Pharma Signs Exclusive Distribution Agreement with Novartis Korea for Domestic Distribution Rights in Korea for Lamisil®, Lescol® XL and Tegretol®
21-08-03
CI
Yuyu Pharma, Inc. announced that it has received KRW 30 billion in funding from a group of investors
21-06-14
CI
Yuyu Pharma, Inc. announced that it expects to receive KRW 30 billion in funding from a group of investors
21-06-10
CI
Yuyu Pharma, Inc. Announces Management Changes
21-05-28
CI
Yuyu Pharma Announces the Introduction of its Global Anti-Corruption Management System
20-10-28
CI
Yuyu Pharma, Inc. announced that it has received KRW 10 billion in funding
20-04-23
CI
Yuyu Pharma, Inc. announced that it expects to receive KRW 10 billion in funding
20-04-21
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Yuyu Pharma, Inc. is a Korea-based company engaged in the provision of pharmaceutical products. The Company produces prescription drugs such as circulatory improvement agents, antiplatelet agents, osteoporosis drugs, antiulcerants, bone metabolism ameliorants, gout preparative drugs, antidepressants, anti-diabetic agents, antitubercular agents, antihypertensive agents, angina pectoris drugs, antibiotics, hemorrhoidal and varicose preparations, topical corticosteroids and others, as well as non-prescription drugs such as vitamins and digestive agents. It also provides healthcare supplements and quasi drugs. In addition, the Company is involved in the provision of medicines for geriatric diseases such as osteoporosis, dementia, stroke and others.
More about the company
1st Jan change
Capi.
-6.63% 57.8M +16.34% 79.03B +8.65% 8.78B -16.73% 4.83B +48.34% 4.65B +2.03% 3.89B +18.40% 2.34B -26.94% 2.18B +16.55% 2.11B -36.25% 2B
Specialty & Advanced Pharmaceuticals
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
YUYU PHARMA, INC. 
